Treace Medical Concepts makes surgical systems and implants for correcting bunions and related midfoot deformities. TMCI reports earnings on Fri, Nov 6, 2026.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Aug 10 | Truist Securities | Target raised | Hold | |
| Jul 16 | Truist Securities | Maintained | Hold |
Whale Options Flow
90DNo whale options trades in TMCI in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether TMCI is in one of them and how their past TMCI trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered TMCI in an article yet. Here's the latest on the wider market.
About Treace Medical Concepts
Treace Medical Concepts is a medical technology company based in Ponte Vedra, Florida. It makes surgical systems, instruments and implants for treating bunions and related midfoot deformities. Its main product line is the Lapiplasty 3D Bunion Correction System, which is supported by options for midfoot correction, minimally invasive osteotomy procedures and great toe fusions. The company sells mainly in the United States to surgeons who treat foot and ankle conditions, including surgical podiatrists and orthopaedic foot and ankle surgeons.
- Headquarters
- Ponte Vedra, FL